Researchers used a customized search engine to quickly find that most discordant resident versus attending physician preliminary reports involved fractures, liver/kidney lesions, pulmonary nodules, and gastrointestinal wall thickening.
Researchers used a customized search engine to quickly find that most discordant resident versus attending physician preliminary reports involved fractures, liver/kidney lesions, pulmonary nodules, and gastrointestinal wall thickening.
"To avoid future misses, residents need to know what they are missing. Attending physicians want to know which areas deserve a second glance, while program directors want to know how to adapt curricula for future learning," said lead author Dr. Dean McNaughton, a radiologist from the University of Iowa, in a scientific poster.
The study focused on 33,000 CT, MRI, ultrasound, and nuclear medicine exams in the emergency room during 2006-2007. The authors analyzed matches generated by the automated search for the keywords "not include" contained in the "report disagree" template, giving them 336 misses.
A missed finding was associated with one or more other abnormal findings in 185 of the 336 misses (55%). Fractures-mostly involving facial bones, transverse processes, or ribs-accounted for 59 misses (18%). Other common misses were hypo- or hyperdense lesions (26), usually in the liver or kidney; pulmonary nodules (20); and gastrointestinal wall thickening or fat stranding (15).
FDA Grants Expanded 510(k) Clearance for Xenoview 3T MRI Chest Coil in GE HealthCare MRI Platforms
November 21st 2024Utilized in conjunction with hyperpolarized Xenon-129 for the assessment of lung ventilation, the chest coil can now be employed in the Signa Premier and Discovery MR750 3T MRI systems.
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.
Ultrasound Device Garners FDA De Novo Nod for Kidney Stone Clearance
November 14th 2024Emerging research demonstrated that the Stone Clear device, which facilitates post-lithotripsy clearance of kidney stone fragments, led to a 70 percent lower risk of relapse in comparison to observation in a control group.